Skip to main content
معتمد ISO 17025

Analytical Method Development & Validation

Custom method development and ICH Q2(R1) validation for novel ingredients and regulatory submissions.

Analytical method development creates custom test procedures for novel ingredients or formulations that lack existing pharmacopeial monographs, followed by ICH Q2(R1) validation covering specificity, linearity, accuracy, precision, and robustness to produce methods suitable for regulatory submission.

Not every ingredient has a pharmacopeial monograph. When existing methods don't fit your product matrix, Qalitex Laboratories develops and validates custom analytical methods tailored to your specific formulation and regulatory requirements.

Method Development Process

Our scientists start with a review of your product, target analyte, and regulatory requirements, then select the appropriate analytical platform (HPLC, GC, ICP-MS, etc.), optimize chromatographic conditions, and establish system suitability criteria. Development is typically completed in 2–4 weeks.

Method Validation (ICH Q2(R1))

Validation per ICH Q2(R1) includes: specificity/selectivity, linearity and range, accuracy (recovery studies), precision (repeatability, intermediate precision), limits of detection (LOD) and quantitation (LOQ), and robustness studies. A full Validation Report is provided for regulatory submission.

Method Transfer

If you are bringing an existing validated method from another laboratory, we perform method transfer studies to confirm the method performs equivalently in our laboratory under ISO 17025 conditions.

الاختبارات والأساليب المدرجة

  • Specificity & selectivity
  • Linearity & range
  • Accuracy (recovery)
  • Precision (repeatability & intermediate)
  • LOD & LOQ determination
  • Robustness & system suitability

المعايير التنظيمية والامتثال

  • ICH Q2(R1) method validation
  • USP <1225> Validation
  • FDA Guidance for Industry (analytical)
  • ISO 17025 accreditation

القطاعات التي نخدمها

  • Novel ingredient suppliers
  • Brands launching first-to-market formulations
  • Regulatory submission support
  • Contract manufacturers
  • Ingredient standardization
ISO 17025

احصل على عرض سعر

يعتمد السعر على منتجك. أخبرنا بما تحتاجه وسنرسل لك عرض سعر مفصلاً خلال 24 ساعة.

احصل على عرض سعر →
📍 إيرفاين · سان دييغو، كاليفورنيا
⏱ 2–4 weeks وقت التسليم
🌍 عملاء حول العالم

الأسئلة الشائعة

When do I need custom method development?

Custom method development is needed when your ingredient or formulation does not have an existing pharmacopeial monograph (USP, AOAC), or when existing methods do not adequately separate or detect your target analyte in your specific product matrix.

What does ICH Q2(R1) method validation include?

ICH Q2(R1) validation includes specificity/selectivity, linearity and range, accuracy through recovery studies, precision (repeatability and intermediate), limits of detection and quantitation (LOD/LOQ), and robustness studies. Qalitex provides a full Validation Report suitable for FDA submission.

How long does method development take at Qalitex?

Method development at Qalitex is typically completed in 2–4 weeks, including analytical platform selection, chromatographic optimization, and system suitability criteria establishment. Full ICH Q2(R1) validation follows development and adds an additional 2–4 weeks.

لماذا تختار العلامات التجارية Qalitex لـ analytical method development & validation

⏱️

تسليم خلال 48 ساعة

CoA موقع في 48–72 ساعة

🔬

وصول مباشر للعلماء

تحدث مع الكيميائي المسؤول عن اختباراتك

🤝

لا حد أدنى للطلب

1 SKU أو 100 — نفس الجودة

هل أنت مستعد لاختبار منتجك؟

أخبرنا بما تحتاج إلى اختباره. سنرد خلال 24 ساعة بالأسعار وأوقات التسليم.

احصل على عرض سعر →

إخلاء المسؤولية: نتائج الاختبارات التي تقدمها Qalitex Laboratories هي بيانات تحليلية لأغراض مراقبة الجودة. لا تشكل مشورة قانونية أو تنظيمية أو امتثالية. يتحمل العملاء المسؤولية الكاملة عن ضمان امتثال منتجاتهم لجميع اللوائح الفيدرالية والولائية والمحلية المعمول بها.